Type 2 diabetes drug could prevent hospitalization and death from COVID-19

Researchers at Penn State University found that the diabetes drugs GLP-1R agonists can reduce a person's risk of being hospitalized or dying from Covid if they take it six months before infection.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news